*AdvaCare Nimustine HCL Powder for Injection is GMP certified.
**AdvaCare Nimustine HCL Powder for Injection is manufactured in our facilities located in China/India/USA.
50mg
10 vials/tray, 1 tray/box
Anticancer, Antineoplastic
Nimustine HCL
Product Information
General Information:
Nimustine HCL is a nitrosourea alkylating agent with antineoplastic activity. Nimustine works by alkylating (adding an alkyl group) and cross-linking DNA, thereby causing DNA fragmentation, inhibition of protein synthesis, and cell death. Nimustine HCL Powder for Injection for injections is used as a treatment for cerebroma, alimentary tract cancer, pulmonary carcinoma, and malignant lymph tumor.
Side Effects:
As with all pharmaceuticals, some unwanted effects can occur from the use of Nimustine HCL Powder for Injection. Always consult a doctor or health care professional for medical advice before use.
For a comprehensive list of all possible effects, consult your doctor.
If any symptom persists or gets worse, or you notice any other symptom, then please call your doctor immediately.
-
For more information about our Nimustine HCL Powder for Injection
email us at: info@advacarepharma.com
Additional Information
Driving or operating machinery should be okay, as it should not cause any relevant symptoms.
Do NOT use Nimustine HCL Powder for Injection if:
- You have bone marrow suppression.
- You are allergic to any component with the powder.
There is little evidence with regards to the use of Nimustine HCL during pregnancy or breast feeding, and so consult your doctor or health care professional before taking Nimustine HCL Powder for Injection.
Refer to your doctor or pharmacist for guidelines on dosage. Do not exceed what they advise. Usual dose for adults is 25mg.
Consult with your doctor about any medications you are taking, before your treatment with Nimustine HCL Powder for Injection.
Interested in more Products?
For more anticancers, you can also check the following related products: